Kainopharm Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.93 Cr
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Kainopharm
Kainopharm Limited (KL) is a Public Limited Indian Non-Government Company incorporated in India on 19 August 2020 (Four years and five months 15 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33100KL2020PLC063719
-
Company No.
063719
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
19 Aug 2020
-
Date of AGM
26 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Kainopharm?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohanakurup Narayanapillai
|
Managing Director | 19-Aug-2020 | Current |
Board Members (13)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Telny Chungath
|
Director | 24-Aug-2020 | Current |
|
Jaison George
|
Director | 19-Aug-2020 | Current |
|
Anilkumar Nair
|
Director | 15-Nov-2020 | Current |
|
Valiyakath Anwar
|
Director | 15-Nov-2020 | Current |
|
Abdul Latheef
|
Director | 24-Aug-2020 | Current |
|
Attupuram Sreekumar
|
Director | 24-Aug-2020 | Current |
Financial Performance of Kainopharm.
Kainopharm Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kainopharm?
Unlock access to Kainopharm's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Homestead Projects And Developers Private LimitedAbdul Latheef is a mutual person
-
Hindustan Bio Sciences LimitedJaison George is a mutual person
-
Aiwon Life Sciences LlpJaison George is a mutual person
-
Harvey Life Sciences Private Limited
Jaison George is a mutual person
-
Asher Bion Pharma Llp
Anilkumar Nair is a mutual person
-
Palmland Apartments & Developers Private Limited
Anilkumar Nair is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kainopharm?
Kainopharm has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kainopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kainopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
